1
Bonita R, Beaglehole R, Kjellström T, et al. Basic epidemiology. 2nd edition. Geneva: World Health Organization 2006.
2
Rose G. Strategy of prevention : lessons from cardiovascular disease. BMJ. 1981;282:1847–51. doi: 10.1136/bmj.282.6279.1847
3
Hart J. Measurement of omission. BMJ. 1982;284:1686–9. doi: 10.1136/bmj.284.6330.1686
4
Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet. 2012;380:37–43. doi: 10.1016/S0140-6736(12)60240-2
5
Ezzati M, Obermeyer Z, Tzoulaki I, et al. Contributions of risk factors and medical care to cardiovascular mortality trends. Nature Reviews Cardiology. 2015;12:508–30. doi: 10.1038/nrcardio.2015.82
6
Richards H, Reid M, Watt G. Socio-economic variations in responses to chest pain : a qualitative study. BMJ. 2002;324:1308–10. doi: 10.1136/bmj.324.7349.1308
7
Jackson R, Wells S, Rodgers A. Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes. BMJ. 2008;337:a1371–a1371. doi: 10.1136/bmj.a1371
8
Capewell S. Will screening individuals at high risk of cardiovascular events deliver large benefits? No. BMJ. 2008;337:a1395–a1395. doi: 10.1136/bmj.a1395
9
Capewell S, Graham H. Will Cardiovascular Disease Prevention Widen Health Inequalities? PLoS Medicine. 2010;7. doi: 10.1371/journal.pmed.1000320
10
Reckless JPD. Primary prevention of cardiovascular disease. BMJ. 2011;342:d201–d201. doi: 10.1136/bmj.d201
11
Hingorani AD, Hemingway H. How should we balance individual and population benefits of statins for preventing cardiovascular disease? BMJ. 2010;342:c6244–c6244. doi: 10.1136/bmj.c6244
12
Khunti K, Walker N, Sattar N, et al. Unanswered questions over NHS health checks. BMJ. 2010;342:c6312–c6312. doi: 10.1136/bmj.c6312
13
O’Donnell CA, Mackenzie M, Reid M, et al. Delivering a national programme of anticipatory care in primary care: a qualitative study. British Journal of General Practice. 2012;62:288–96. doi: 10.3399/bjgp12X636137
14
Linardakis M, Smpokos E, Papadaki A, et al. Prevalence of multiple behavioral risk factor for chronic diseases in adults aged 50+, from eleven European countries – the SHARE study (2004). ;57 (3):168–72.
15
Prochazka AV, Caverly T. General Health Checks in Adults for Reducing Morbidity and Mortality From Disease. JAMA Internal Medicine. 2013;173. doi: 10.1001/jamainternmed.2013.3187
16
Artac M, Dalton A, Majeed A, et al. Effectiveness of a national cardiovascular disease risk assessment program (NHS Health Check): Results after one year. 2013;57 (2):129–34.
17
World Health Organization pages on Cardiovascular Disease. http://www.who.int/cardiovascular_diseases/en/
18
WHO Factsheet No 317 on Cardiovascular Diseases (CVDs) – updated January 2015. http://www.who.int/mediacentre/factsheets/fs317/en/
19
WHO Global Atlas on CVD Prevention and Control. http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/
20
WHO Global Status Report on Noncommunicable Diseases 2014. http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1
21
Cleland J, Dargie H, Hardman S, et al. National heart failure audit. April 2012-March 2013. 2013.
22
Acute heart failure: diagnosis and management (NICE guidelines [CG187]).
23
Chronic heart failure in adults: management (NICE guidelines [CG108]).
24
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2016;37:2129–200. doi: 10.1093/eurheartj/ehw128
25
McAlister FA, Stewart S, Ferrua S, et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission. Journal of the American College of Cardiology. 2004;44:810–9. doi: 10.1016/j.jacc.2004.05.055
26
Sochalski J, Jaarsma T, Krumholz HM, et al. What Works In Chronic Care Management: The Case Of Heart Failure. Health Affairs. 2009;28:179–89. doi: 10.1377/hlthaff.28.1.179
27
McMurray JJV, Packer M, Desai AS, et al. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure. New England Journal of Medicine. 2014;371:993–1004. doi: 10.1056/NEJMoa1409077
28
Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136:e137–61. doi: 10.1161/CIR.0000000000000509
29
Cleland J. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis. European Heart Journal. 2003;24:442–63. doi: 10.1016/S0195-668X(02)00823-0
30
SIGN 147: Management of chronic heart failure. A national clinical guideline. 2016.
31
Ezekowitz JA, O’Meara E, McDonald MA, et al. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Canadian Journal of Cardiology. 2017;33:1342–433. doi: 10.1016/j.cjca.2017.08.022
32
Baron-Franco B, McLean G, Mair FS, et al. Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care. British Journal of General Practice. 2017;67:e314–20. doi: 10.3399/bjgp17X690533
33
Royal College of Physicians of Edinburgh Consensus Statement on Atrial Fibrillation. 2012.
34
National clinical guidelines centre. Atrial fibrillation: The management of atrial fibrillation. 2014.
35
European society of cardiology. Atrial Fibrillation 2016 (Management of) ESC Clinical Practice Guidelines. 2016. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Atrial-Fibrillation-Management
36
Heidbuchel H, Verhamme P, Alings M, et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015;17:1467–507. doi: 10.1093/europace/euv309
37
Jani BD, Nicholl BI, McQueenie R, et al. Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. EP Europace. Published Online First: 2 November 2017. doi: 10.1093/europace/eux322
38
Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). European Heart Journal. 2009;30:2631–71. doi: 10.1093/eurheartj/ehp298
39
National Institute for Health and Care Excellence (NICE). Transient loss of consciousness ('blackouts’) management in adults and young people.
40
Brignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope – Update 2004. European Heart Journal. 2004;25:2054–72. doi: 10.1016/j.ehj.2004.09.004
41
Kabat H, Anderson JP. Acute Arrest of Cerebral Circulation in Man. Archives of Neurology & Psychiatry. 1943;50:510–28. doi: 10.1001/archneurpsyc.1943.02290230022002
42
Determining driver fitness in Canada.
43
Scottish Intercollegiate Guidelines Network (SIGN). Cardiac arrhythmias in coronary heart disease. 2018.
44
CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. The Lancet. 2015;385:2383–91. doi: 10.1016/S0140-6736(15)60291-4
45
Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease. New England Journal of Medicine. 2015;372:1291–300. doi: 10.1056/NEJMoa1415516
46
European Society of Cardiology. Stable Coronary Artery Disease (Management of) ESC Clinical Practice Guidelines. European Heart Journal. 2013. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Stable-Coronary-Artery-Disease-Management-of
47
SIGN 96 Scottish Intercollegiate Guidelines Network. management of stable angina.
48
Angina - NICE CKS. https://cks.nice.org.uk/angina
49
Scottish Intercollegiate Guidelines Network (SIGN). Management of stable angina. 2018.
50
Gan Y, Gong Y, Tong X, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2014;14. doi: 10.1186/s12888-014-0371-z
51
Thombs BD, Bass EB, Ford DE, et al. Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine. 2006;21:30–8. doi: 10.1111/j.1525-1497.2005.00269.x
52
Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations: A Scientific Statement From the American Heart Association. Circulation. 2014;129:1350–69. doi: 10.1161/CIR.0000000000000019
53
Meijer A, Conradi HJ, Bos EH, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. General Hospital Psychiatry. 2011;33:203–16. doi: 10.1016/j.genhosppsych.2011.02.007
54
Hare DL, Toukhsati SR, Johansson P, et al. Depression and cardiovascular disease: a clinical review. European Heart Journal. 2014;35:1365–72. doi: 10.1093/eurheartj/eht462
55
Meijer A, Zuidersma M, de Jonge P. Depression as a non-causal variable risk marker in coronary heart disease. BMC Medicine. 2013;11. doi: 10.1186/1741-7015-11-130
56
Thombs BD, Roseman M, Coyne JC, et al. Does Evidence Support the American Heart Association’s Recommendation to Screen Patients for Depression in Cardiovascular Care? An Updated Systematic Review. PLoS ONE. 2013;8. doi: 10.1371/journal.pone.0052654
57
Whooley MA, P de J, E V, et al. Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease. JAMA. 2008;300. doi: 10.1001/jama.2008.711
58
Poole L, Dickens C, Steptoe A. The puzzle of depression and acute coronary syndrome: Reviewing the role of acute inflammation. Journal of Psychosomatic Research. 2011;71:61–8. doi: 10.1016/j.jpsychores.2010.12.009
59
Harris P, Sommargren C, Stein P, et al. Heart rate variability measurement and clinical depression in acute coronary syndrome patients: narrative review of recent literature. Neuropsychiatric Disease and Treatment. Published Online First: July 2014. doi: 10.2147/NDT.S57523
60
R von K. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? Acta Psychiatr Scand. 2004;110. doi: 10.1111/j.1600-0447.2004.00308.x
61
Jokinen J, Nordström P. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. Journal of Affective Disorders. 2009;116:88–92. doi: 10.1016/j.jad.2008.10.025
62
Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd 1996.
63
Tully PJ, Baumeister H. Collaborative care for comorbid depression and coronary heart disease: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2015;5. doi: 10.1136/bmjopen-2015-009128
64
McMurray JJV, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2012;33:1787–847. doi: 10.1093/eurheartj/ehs104
65
Jaarsma T, Beattie JM, Ryder M, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2009;11:433–43. doi: 10.1093/eurjhf/hfp041
66
End of life care in heart failure. A framework for implementation. 2014.
67
Living and dying well: a national action plan for palliative care and end of life care in Scotland. 2008.
68
Living and dying with advanced heart failure: a palliative care approach. 2008.
69
Hogg KJ, Jenkins SMM. Prognostication or identification of palliative needs in advanced heart failure: where should the focus lie? Heart. 2012;98:523–4. doi: 10.1136/heartjnl-2012-301753
70
Johnson M, Beattie J, Hogg K, et al. Heart failure: from advanced disease to bereavement. Oxford: Oxford University Press 2012.
71
Browne S, Macdonald S, May CR, et al. Patient, Carer and Professional Perspectives on Barriers and Facilitators to Quality Care in Advanced Heart Failure. PLoS ONE. 2014;9. doi: 10.1371/journal.pone.0093288
72
Pettit SJ, Browne S, Hogg KJ, et al. ICDs in end-stage heart failure. BMJ Supportive & Palliative Care. 2012;2:94–7. doi: 10.1136/bmjspcare-2011-000176
73
Fang JC, Ewald GA, Allen LA, et al. Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines Committee. Journal of Cardiac Failure. 2015;21:519–34. doi: 10.1016/j.cardfail.2015.04.013
74
Cowie MR, Bax J, Bruining N, et al. e-Health: a position statement of the European Society of Cardiology. European Heart Journal. 2016;37:63–6. doi: 10.1093/eurheartj/ehv416
75
Widmer RJ, Collins NM, Collins CS, et al. Digital Health Interventions for the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis. Mayo Clinic Proceedings. 2015;90:469–80.
76
Inglis SC, Clark RA, McAlister FA, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database of Systematic Reviews. Published Online First: 1 September 1996. doi: 10.1002/14651858.CD007228.pub2
77
Frederix I, Hansen D, Coninx K, et al. Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial. Journal of Medical Internet Research. 2015;17. doi: 10.2196/jmir.4799
78
E-Health Strategy 2011-2017.
79
Murray E, Burns J, May C, et al. Why is it difficult to implement e-health initiatives? A qualitative study. Implementation Science. 2011;6. doi: 10.1186/1748-5908-6-6
80
Mair FS, May C, O’Donnell C, et al. Factors that promote or inhibit the implementation of e-health systems: an explanatory systematic review. Bulletin of the World Health Organization. 2012;90:357–64. doi: 10.2471/BLT.11.099424
81
Burke LE, Ma J, Azar KMJ, et al. Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention. Circulation. 2015;132:1157–213. doi: 10.1161/CIR.0000000000000232
82
O’Connor S, Hanlon P, O’Donnell CA, et al. Understanding factors affecting patient and public engagement and recruitment to digital health interventions: a systematic review of qualitative studies. BMC Medical Informatics and Decision Making. 2016;16. doi: 10.1186/s12911-016-0359-3
83
Lennon MR, Bouamrane M-M, Devlin AM, et al. Readiness for Delivering Digital Health at Scale: Lessons From a Longitudinal Qualitative Evaluation of a National Digital Health Innovation Program in the United Kingdom. Journal of Medical Internet Research. 2017;19. doi: 10.2196/jmir.6900
84
Mair FS, May CR. Thinking about the burden of treatment. BMJ. 2014;349:g6680–g6680. doi: 10.1136/bmj.g6680
85
May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ. 2009;339:b2803–b2803. doi: 10.1136/bmj.b2803
86
Abu Dabrh AM, Gallacher K, Boehmer KR, et al. Minimally disruptive medicine: the evidence and conceptual progress supporting a new era of healthcare. Journal of the Royal College of Physicians of Edinburgh. 2015;45:114–7.
87
Shippee ND, Allen SV, Leppin AL, et al. Attaining minimally disruptive medicine: context, challenges and a roadmap for implementation. Journal of the Royal College of Physicians of Edinburgh. 2015;45:118–22.
88
Gallacher K, May CR, Montori VM, et al. Understanding Patients’ Experiences of Treatment Burden in Chronic Heart Failure Using Normalization Process Theory. The Annals of Family Medicine. 2011;9:235–43. doi: 10.1370/afm.1249
89
Shippee ND, Shah ND, May CR, et al. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. Journal of Clinical Epidemiology. 2012;65:1041–51. doi: 10.1016/j.jclinepi.2012.05.005
90
May CR, Eton DT, Boehmer K, et al. Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Services Research. 2014;14. doi: 10.1186/1472-6963-14-281
91
Jani B, Blane D, Browne S, et al. Identifying treatment burden as an important concept for end of life care in those with advanced heart failure. Current Opinion in Supportive and Palliative Care. 2013;7:3–7. doi: 10.1097/SPC.0b013e32835c071f
92
Gallacher K, Morrison D, Jani B, et al. Uncovering Treatment Burden as a Key Concept for Stroke Care: A Systematic Review of Qualitative Research. PLoS Medicine. 2013;10. doi: 10.1371/journal.pmed.1001473
